| （単位：千ドル） | 2Q21 | 3Q21 | 1Q22 | 2Q22 | 3Q22 | 1Q23 | 2Q23 | 3Q23 | 1Q24 | 2Q24 | 3Q24 | 1Q25 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 売上高 | - | - | 553 | 35,741 | 3 | 65 | 27 | 25 | 3 | 13 | 34 | 7 |
| 売上成長率（％） | - | - | - | - | - | |||||||
| 研究開発費 | - | - | 35,830 | 43,719 | 41,607 | 44,630 | 47,471 | 43,849 | 43,174 | 40,261 | 39,500 | 43,447 |
| 営業費用 | - | - | 69,129 | 73,002 | 66,440 | 62,621 | 65,932 | 59,064 | 55,578 | 51,541 | 50,539 | 57,374 |
| 営業利益 | - | - | -68,576 | -37,261 | -66,437 | -62,556 | -65,905 | -59,039 | -55,575 | -51,528 | -50,505 | -57,367 |
| 営業利益率 (%) | - | - | ||||||||||
| 純利益 | -62,595 | -48,875 | -68,144 | -36,323 | -70,254 | -66,959 | -63,890 | -50,853 | -60,667 | -45,809 | -44,583 | -52,195 |
| 純利益率（％） | - | - | ||||||||||
| 一株あたり利益 | - | - | -0.28 | -0.15 | -0.28 | -0.27 | -0.26 | -0.2 | -0.24 | -0.18 | -0.17 | -0.18 |
| 希薄化後一株あたり利益 | - | - | -0.28 | -0.15 | -0.28 | -0.27 | -0.26 | -0.2 | -0.24 | -0.18 | -0.17 | -0.18 |
| EBITDA | - | - | - | - | - | - | - | - | ||||
| EBITDAマージン（％） | - | - | - | - | - | - | - | - |